Deep Currents Investment Group LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $87.7 Million distributed in 313 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nvidia Corp with a value of $19.2M, Western Digital Corp with a value of $11.9M, Ishares Russell 2000 ETF with a value of $10M, Jazz Pharmaceuticals PLC with a value of $7.07M, and Azek CO Inc. with a value of $6M.
Examining the 13F form we can see an increase of $420K in the current position value, from $87.3M to 87.7M .
Deep Currents Investment Group LLC is based out at New York, NY
Below you can find more details about Deep Currents Investment Group LLC portfolio as well as his latest detailed transactions.
Portfolio value
$87.7 Million
$34 Million
$14.7 Million
$11.1 Million
$10.8 Million
$4.08 Million
$3.47 Million
$3.41 Million
$2.29 Million
$3.86 Million
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 22.22%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 616.84%
-
$0
0.0% of portfolio
-
Q4 2024
Added 6.82%
-
$0
0.0% of portfolio
-
Q2 2025
Added 18.44%
-
$0
0.0% of portfolio
-
Q4 2024
Added 22.39%
-
$0
0.0% of portfolio
-
Q2 2025
Added 16.72%
-
$0
0.0% of portfolio
-
Q1 2025
Added 83.67%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 20.33%
-
$0
0.0% of portfolio
-
Q2 2025
Added 24.43%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 24.71%
-
$0
0.0% of portfolio
-
Q1 2025
Added 21.43%
-
$0
0.0% of portfolio
-
Q3 2024
Added 50.26%
Solaredge Technologies Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 14.82%
-
$0
0.0% of portfolio
-
Q2 2025
Added 4.15%
-
$0
0.0% of portfolio
-
Q3 2024
Added 10.69%
Purecycle Technologies Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 59.8%
-
$0
0.0% of portfolio
-
Q2 2025
Added 7.15%
-
$0
0.0% of portfolio
-
Q2 2025
Added 21.45%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 7.93%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 51.23%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 73.9%
-
$0
0.0% of portfolio
-
Q2 2025
Added 28.64%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 77.18%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 10.75%
-
$0
0.0% of portfolio
-
Q2 2025
Added 29.18%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 60.0%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 5.52%
-
$0
0.0% of portfolio
-
Q1 2025
Added 4.12%
-
$0
0.0% of portfolio
-
Q1 2025
Added 43.58%
-
$0
0.0% of portfolio
-
Q2 2025
Added 13.33%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2023
Added 48.37%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 11.92%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 91.46%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 12.04%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.75%
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.67%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 28.27%
